ArticleExperimental and therapeutic medicine2016

Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis.

Shizhao Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.